Circulation Research, Vol 63, 373-379, Copyright © 1988 by American Heart Association

ARTICLES

Humoral regulation of blood flow to choroid plexus: role of arginine vasopressin

FM Faraci, WG Mayhan, WJ Farrell and DD Heistad
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.

The goal of this study was to examine humoral mechanisms that regulate blood flow to the choroid plexus. We determined the effects of arginine vasopressin on blood flow (microspheres) to the choroid plexus in anesthetized and awake rabbits. In anesthetized rabbits, blood flow to the choroid plexus was 342 +/- 31 (mean +/- SEM) ml/min/100 g under control conditions. Intravenous infusion of vasopressin at 4 and 40 mU/kg increased plasma vasopressin levels from 11 +/- 1 to 55 +/- 15 and 441 +/- 120 pg/ml, respectively, and blood flow to the choroid plexus decreased by 48 +/- 6% and 70 +/- 4%. Cerebral blood flow was not affected by infusion of vasopressin. Similar responses to infusion of vasopressin were observed in awake rabbits. The V1 antagonist [d(CH2)5Tyr(Me)AVP] (10 micrograms/kg i.v.) had no effect on resting blood flow, but abolished the effect of vasopressin on blood flow to the choroid plexus. Vasoconstrictor responses of the choroid plexus to intravenous infusion of phenylephrine were not attenuated by the V1 antagonist. Thus, circulating vasopressin, at plasma levels that are observed under physiological and pathophysiological conditions, has marked effects on blood flow to the choroid plexus. These effects appear to be mediated through a V1 receptor. We speculate that vasopressin may play an important role in regulation of blood flow to the choroid plexus and perhaps in the regulation of cerebrospinal fluid production.

This article has been cited by other articles:

				A. Shuaib, C. Xu Wang, T. Yang, and R. Noor Effects of Nonpeptide V1 Vasopressin Receptor Antagonist SR-49059 on Infarction Volume and Recovery of Function in a Focal Embolic Stroke Model Stroke, December 1, 2002; 33(12): 3033 - 3037. [Abstract] [Full Text] [PDF]

				C. E. Johanson, J. E. Preston, A. Chodobski, E. G. Stopa, J. Szmydynger-Chodobska, and P. N. McMillan AVP V1 receptor-mediated decrease in Cl- efflux and increase in dark cell number in choroid plexus epithelium Am J Physiol Cell Physiol, January 1, 1999; 276(1): C82 - C90. [Abstract] [Full Text] [PDF]

				C. Vaccari, S. J. Lolait, and N. L. Ostrowski Comparative Distribution of Vasopressin V1b and Oxytocin Receptor Messenger Ribonucleic Acids in Brain Endocrinology, December 1, 1998; 139(12): 5015 - 5033. [Abstract] [Full Text] [PDF]

				A. Chodobski, J. Szmydynger-Chodobska, and M. J. McKinley Cerebrospinal fluid formation and absorption in dehydrated sheep Am J Physiol Renal Physiol, August 1, 1998; 275(2): F235 - F238. [Abstract] [Full Text] [PDF]

				J. A. Ulatowski, E. Bucci, A. Razynska, R. J. Traystman, and R. C. Koehler Cerebral blood flow during hypoxic hypoxia with plasma-based hemoglobin at reduced hematocrit Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1933 - H1942. [Abstract] [Full Text] [PDF]

				F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]

				E. Kozniewska, T. P. L. Roberts, Z. S. Vexler, M. Oseka, J. Kucharczyk, and A. I. Arieff Hormonal Dependence of the Effects of Metabolic Encephalopathy on Cerebral Perfusion and Oxygen Utilization in the Rat Circ. Res., April 1, 1995; 76(4): 551 - 558. [Abstract] [Full Text]